The typical KMT2A-r ALL immunophenotype has the CD19- positive, CD10-negative B-lymphoblastic cells, often co-expressed with myeloid-related antigens (for example, CD15, CD33, and CD68 antigens). The gene discussed is CD19; the disease is acute lymphoblastic leukemia.